SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6
http://www.w3.org/2000/01/rdf-schema#comment
"The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway."
xsd:string
http://purl.uniprot.org/uniprot/#_B9FA90C626C330DD9EF0CAC1D1890E29D8C98D8A3C3FD76D3490282E9B211F5D15930B013D37F59CFC6115747BE9BEF6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6
http://purl.uniprot.org/uniprot/O14682
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6
http://purl.uniprot.org/uniprot/#_O14682-mappedCitation-35015607
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A65FCB92F00674836AF9465ACA5A7D8F78E6BC0AEEAE8D47DDC39DF9594D76F39D33373C7CA4FC1D63BBE2F5D97FC7B6